Prostate Volume — Ellipsoid Formula
Volume · PSA Density · Weight · BPH Classification
Prostate Volume — Clinical Reference
Normal Prostate Volume by Age
Prostate volume increases with age due to benign prostatic hyperplasia (BPH). Volume alone does not determine symptoms — the degree of bladder outlet obstruction and patient bother guide treatment decisions. The following ranges are established from population-level TRUS studies.
| Age Group | Typical Volume | BPH Grade | Clinical Relevance |
|---|---|---|---|
| 30–40 years | 15–25 mL | Normal | Baseline; BPH rarely symptomatic |
| 41–50 years | 20–30 mL | Normal to mildly enlarged | Early BPH may begin; screen if LUTS present |
| 51–60 years | 25–40 mL | Mildly enlarged | IPSS + TRUS recommended if symptomatic |
| 61–70 years | 35–55 mL | Moderately enlarged | Medical therapy (alpha-blockers ± 5-ARIs) considered |
| 71–80 years | 45–80 mL | Moderately–significantly enlarged | Assess for urinary retention, hydronephrosis |
| 80+ years | 50–100+ mL | Significantly enlarged | Surgical planning (HoLEP/TURP) if refractory |
PSA Density (PSAD) — Interpretation
PSA density refines the interpretation of total PSA, particularly in the diagnostic grey zone of 4–10 ng/mL where total PSA alone cannot reliably distinguish BPH from prostate cancer. PSAD corrects for the contribution of benign prostatic tissue to PSA secretion.
| PSAD (ng/mL/mL) | Interpretation | Recommendation |
|---|---|---|
| <0.10 | Low — PSA likely from BPH | Active surveillance; repeat PSA in 12 months |
| 0.10–0.15 | Borderline | Consider free/total PSA ratio; counsel and monitor |
| >0.15 | Elevated — cancer cannot be excluded | Biopsy discussion; MRI prostate (PI-RADS) recommended |
| >0.25 | High suspicion | Prompt urology referral; targeted biopsy preferred |
BPH Treatment by Prostate Volume
Prostate volume guides selection of medical and surgical therapy. The table below reflects EAU and AUA guidelines, which are broadly followed by Indian urologists. Note that alpha-blockers improve symptoms regardless of prostate size; 5-ARIs are volume-dependent and most effective in prostates ≥40 mL.
| Volume | Preferred Medical Therapy | Surgical Options |
|---|---|---|
| <30 mL | Alpha-blocker (tamsulosin 0.4 mg) alone | TUIP if refractory |
| 30–40 mL | Alpha-blocker ± 5-ARI (if PSA >1.4) | TURP (standard) |
| 40–80 mL | Combination: tamsulosin + dutasteride/finasteride | TURP, HoLEP, or TUMT |
| 80–150 mL | Combination therapy + reassess every 3–6 months | HoLEP preferred over TURP |
| >150 mL | Medical bridge; surgical planning | Open simple prostatectomy / HoLEP |
How Prostate Volume Is Measured
The most accurate method is transrectal ultrasound (TRUS), which allows direct visualisation in sagittal and transverse planes. The probe is placed in the rectum; three orthogonal diameters are measured: anteroposterior (AP), transverse (width), and cranio-caudal (length). MRI prostate is increasingly used and provides superior soft-tissue contrast for simultaneous cancer staging.
Transabdominal ultrasound (TAUS) is less accurate for prostate volume but suitable for screening in primary care. DRE (digital rectal examination) estimates volume subjectively and underestimates large glands; it remains part of the clinical examination but should not replace TRUS for treatment planning.
Ellipsoid Formula — How This Calculator Works
This calculator uses the standard ellipsoid formula: V = Length × Width × AP × 0.523, where 0.523 = π/6 ≈ 0.5236. All measurements are entered in centimetres and the result is given in millilitres (mL), since 1 cm³ = 1 mL. Prostate weight (grams) is derived by multiplying by tissue density (1.05 g/mL), though for practical purposes volume in mL ≈ weight in grams.
Frequently Asked Questions — Prostate Volume
What is the normal prostate volume?
The normal prostate volume in adult men is 20–30 mL. A volume of 30–50 mL is considered mildly enlarged, 50–80 mL moderately enlarged, and above 80 mL significantly enlarged. Prostate volume increases with age, so what is normal at 40 differs from normal at 70. The key clinical question is not just size but whether symptoms (LUTS) are present and whether bladder outlet obstruction is demonstrated.
What is PSA density and when should I calculate it?
PSA density (PSAD) = serum PSA ÷ prostate volume in mL. It is most useful when total PSA is in the grey zone of 4–10 ng/mL, where it is difficult to distinguish BPH from prostate cancer based on total PSA alone. A PSAD above 0.15 ng/mL/mL raises concern for prostate cancer; below 0.10 ng/mL/mL suggests the PSA is explained by BPH. Free/total PSA ratio is complementary — a ratio below 15% also increases cancer suspicion.
What is the IPSS score and what does it mean?
The International Prostate Symptom Score (IPSS) is a validated 7-question questionnaire that quantifies lower urinary tract symptoms (LUTS) over the past month. Scores: 0–7 = mild (watchful waiting), 8–19 = moderate (medical therapy), 20–35 = severe (surgical evaluation). The quality-of-life (bother) question is assessed separately and often drives treatment decisions more than the symptom score alone.
When are 5-alpha reductase inhibitors (finasteride/dutasteride) indicated?
5-ARIs are indicated when prostate volume is ≥40 mL (or ≥30 mL with PSA >1.4 ng/mL). They reduce prostate volume by 20–30% over 6–12 months and reduce the risk of acute urinary retention and need for surgery. They are ineffective in small prostates. The combination of tamsulosin + dutasteride (CombAT study) is superior to either alone for moderate-to-severe LUTS in men with enlarged prostates.
What prostate volume requires surgery?
Surgical intervention is considered when medical therapy fails, when there are absolute indications (acute urinary retention refractory to catheter removal, recurrent UTIs, bladder stones, renal impairment from BPH), or when the patient prefers definitive treatment. TURP is standard for 30–80 mL. HoLEP (holmium laser enucleation of the prostate) has no upper size limit and is preferred for large prostates (>80 mL) in centres where it is available.
How accurate is prostate volume measurement by ultrasound?
TRUS with the ellipsoid formula has a ±10–20% variability compared to pathological weight on prostatectomy specimens. The main sources of error are: examiner experience, probe angle, and patient cooperation. MRI planimetry is more accurate but not routinely used for volume alone. For clinical purposes — treatment planning and PSA density — TRUS ellipsoid volume is sufficient and is the standard of care.
What is considered a large prostate in India?
In Indian men, BPH and LUTS are common from the fifth decade onward. A prostate above 40 mL is considered significantly enlarged for clinical management purposes in most Indian urological practice, with volumes above 80 mL typically requiring discussion of HoLEP or open prostatectomy. Indian men may present later with larger prostates due to delayed health-seeking. PSA levels in Indian men follow similar distributions to Western populations, though formal Indian-specific age-adjusted PSA norms are not yet universally adopted.